Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Joanne Enticott

2 papers in the library · 66 citations · publishing 2014-2020

Papers

Mindfulness-based cognitive therapy for recurrent depression: A translational research study with 2-year follow-up

Australian & New Zealand Journal of Psychiatry March 4, 2014 Graham Meadows, Frances Shawyer, Joanne Enticott et al. 66 citations

Mindfulness-based cognitive therapy (MBCT) plus active monitoring reduced the average number of days with major depression over two years to 65, compared to 112 for active monitoring alone. Proportionally fewer MBCT participants experienced relapse in both the first and second year (odds ratio 0.45). The difference in time to first depressive episode was not statistically significant, though trends favored MBCT. MBCT was most effective for people receiving specialist care and for those taking antidepressant or mood stabilizer medication. The findings support MBCT's effectiveness in routine practice, with effects less strong than in prior efficacy studies but still appreciable.

DOI: 10.1177/0004867414525841 (opens in new tab) Depression economics Psychotherapist Mindfulness-based cognitive therapy Cognition +4

Study protocol for a randomized control trial to investigate the effectiveness of an 8-week mindfulness-integrated cognitive behavior therapy (MiCBT) transdiagnostic group intervention for primary care patients.

BMC Psychiatry January 6, 2020 Sarah Frances, Frances Shawyer, Bruno Cayoun et al.

A transdiagnostic treatment called mindfulness-integrated cognitive behavior therapy (MiCBT) combines cognitive behavioral techniques with mindfulness meditation from the Vipassana tradition, focusing on body scanning to develop interoceptive awareness and equanimity. This randomized controlled trial will test whether group MiCBT reduces depression and anxiety symptoms in 120 adults with high psychological distress (K10 score of 20 or more) recruited from primary care. Participants will be assigned to an 8-week MiCBT program or a wait-list control group, with outcomes measured using the DASS-21 and K10. The study aims to determine if MiCBT offers a comprehensive therapeutic system applicable across diagnostic groups.

DOI: 10.1186/s12888-019-2411-1 (opens in new tab) Full text (opens in new tab) Anxiety Depression Equanimity Group therapy +3